BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1868116)

  • 21. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
    Scammells PJ; Baker SP; Belardinelli L; Olsson RA
    J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoionic xanthine analogues: antagonists of adenosine receptors.
    Glennon RA; Tejani-Butt SM; Padgett W; Daly JW
    J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
    Kim HO; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
    J Med Chem; 1994 Sep; 37(20):3373-82. PubMed ID: 7932565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
    Jacobson KA; Kirk KL; Padgett WL; Daly JW
    Mol Pharmacol; 1986 Feb; 29(2):126-33. PubMed ID: 3005825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xanthine functionalized congeners as potent ligands at A2-adenosine receptors.
    Jacobson KA; Ukena D; Padgett W; Daly JW; Kirk KL
    J Med Chem; 1987 Jan; 30(1):211-4. PubMed ID: 3806597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U; Ukena D; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Zhou QY; Li C; Olah ME; Johnson RA; Stiles GL; Civelli O
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7432-6. PubMed ID: 1323836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
    Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine receptors: development of selective agonists and antagonists.
    Daly JW; Jacobson KA; Ukena D
    Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
    Stiles GL; Jacobson KA
    Mol Pharmacol; 1988 Dec; 34(6):724-8. PubMed ID: 3200248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.
    Dennis D; Jacobson K; Belardinelli L
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H661-71. PubMed ID: 1558173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Cleavable trifunctional" approach to receptor affinity labeling: chemical regeneration of binding to A1-adenosine receptors.
    Jacobson KA; Fischer B; Ji XD
    Bioconjug Chem; 1995; 6(3):255-63. PubMed ID: 7632796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.
    Jacobson KA; Ukena D; Kirk KL; Daly JW
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4089-93. PubMed ID: 3012550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.
    Collis MG; Jacobson KA; Tomkins DM
    Br J Pharmacol; 1987 Sep; 92(1):69-75. PubMed ID: 3664093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.
    Ramkumar V; Barrington WW; Jacobson KA; Stiles GL
    Mol Pharmacol; 1990 Feb; 37(2):149-56. PubMed ID: 2304450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain.
    Hawkins M; Dugich MM; Porter NM; Urbancic M; Radulovacki M
    Brain Res Bull; 1988 Sep; 21(3):479-82. PubMed ID: 3214753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
    Thompson RD; Secunda S; Daly JW; Olsson RA
    J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.